Letter Re: “A stromal–immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study”
Elsevier ·
The publisher did not provide an abstract — full text is available via the link below.
Letter Re: “A stromal–immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study”. // European Journal of Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S0959804926015492?dgcid=rss_sd_all
Letter Re: “A stromal–immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study”. European Journal of Cancer. https://www.sciencedirect.com/science/article/pii/S0959804926015492?dgcid=rss_sd_all
“Letter Re: “A stromal–immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study”.” European Journal of Cancer.
@article{article45020,
title = {Letter Re: “A stromal–immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study”},
journal = {European Journal of Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S0959804926015492?dgcid=rss_sd_all}
}